CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Feb. 28, 2021 |
Feb. 29, 2020 |
Feb. 28, 2021 |
Feb. 29, 2020 |
May 31, 2020 |
May 31, 2019 |
|
| Income Statement [Abstract] | ||||||
| Revenue | $ 4,544,082 | $ 3,224,170 | $ 13,232,840 | $ 9,139,616 | $ 11,917,629 | $ 8,459,048 |
| Cost of goods sold | 2,488,906 | 1,537,960 | 6,487,089 | 4,537,164 | 5,959,286 | 4,836,166 |
| Gross margin | 2,055,176 | 1,686,210 | 6,745,751 | 4,602,452 | 5,958,343 | 3,622,882 |
| Selling, general and administrative expenses | 2,511,502 | 2,213,206 | 7,717,063 | 6,533,173 | 8,776,876 | 26,472,057 |
| Impairment of goodwill | 0 | 0 | 0 | 0 | 25,185,003 | 0 |
| Total operating expenses | 2,511,502 | 2,213,206 | 7,717,063 | 6,533,173 | 33,961,879 | 26,472,057 |
| Operating loss | (456,326) | (526,996) | (971,312) | (1,930,721) | (28,003,536) | (22,849,175) |
| Other (income) expense: | ||||||
| Interest expense, net | 757,740 | 725,003 | 2,237,166 | 2,254,752 | 2,941,131 | 4,447,993 |
| Impairment of note receivable | 2,498,706 | 0 | 2,498,706 | 0 | 0 | |
| Gain on settlement of liabilities | 0 | 0 | 0 | (275,000) | (275,000) | 0 |
| Gain on modification of operating leases | 0 | 0 | 0 | 0 | (28,511) | 0 |
| Loss on disposal of assets | 0 | 0 | 0 | 0 | 16,817 | 0 |
| Loss on revaluation of contingent liability | 0 | 0 | 0 | 0 | 0 | 321,889 |
| Total other expense | 3,256,446 | 725,003 | 4,735,872 | 1,979,752 | 2,654,437 | 4,769,882 |
| Loss before income taxes | (3,712,772) | (1,251,999) | (5,707,184) | (3,910,473) | (30,657,973) | (27,619,057) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net loss | $ (3,712,772) | $ (1,251,999) | $ (5,707,184) | $ (3,910,473) | $ (30,657,973) | $ (27,619,057) |
| Net loss per share - basic (in Dollars per share) | $ (0.03) | $ (0.01) | $ (0.05) | $ (0.03) | $ (0.24) | $ (0.27) |
| Net loss per share - diluted (in Dollars per share) | $ (0.03) | $ (0.01) | $ (0.05) | $ (0.03) | $ (0.24) | $ (0.27) |
| Weighted average shares outstanding - basic (in Shares) | 126,635,303 | 126,470,865 | 126,568,117 | 126,343,206 | 126,390,105 | 102,869,612 |
| Weighted average shares outstanding - diluted (in Shares) | 126,635,303 | 126,470,865 | 126,568,117 | 126,343,206 | 126,390,105 | 102,869,612 |
| X | ||||||||||
- Definition Gain on settlement of debt. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of other assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|